Bentham Science Logo

CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

Volume 18, 10 Issues, 2019
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access

Ranking and Category

  • 150th of 267 in

    Neurosciences

  • 119th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

CNS & Neurological Disorders - Drug Targets , Volume 13 - Number 3




Current Acetylcholinesterase-Inhibitors: A Neuroinformatics Perspective

, 13(3): 391 - 401

Sibhghatulla Shaikh, Anupriya Verma, Saimeen Siddiqui, Syed S. Ahmad, Syed M.D. Rizvi, Shazi Shakil, Deboshree Biswas, Divya Singh, Mohmmad H. Siddiqui, Shahnawaz Shakil, Shams Tabrez and Mohammad A. Kamal


DOI: 10.2174/18715273113126660166



Diabetes of the Brain: Computational Approaches and Interventional Strategies

, 13(3): 408 - 417

Kothandaraman Narasimhan, Meenakumari Govindasamy, Kalamegam Gauthaman, Mohammad A. Kamal, Adel M. Abuzenadeh, Mohammed Al-Qahtani and Rajaraman Kanagasabai


DOI: 10.2174/18715273113126660156


Does Parkinson’s Disease and Type-2 Diabetes Mellitus Present Common Pathophysiological Mechanisms and Treatments?

, 13(3): 418 - 428

Marcelo M.S. Lima, Adriano D.S. Targa, Ana C.D. Noseda, Lais S. Rodrigues, Ana Marcia Delattre, Fabiola V. dos Santos, Mariana H. Fortes, Maira J. Maturana and Anete C. Ferraz


DOI: 10.2174/18715273113126660155


An Association of Virus Infection with Type 2 Diabetes and Alzheimer’s Disease

, 13(3): 429 - 439

Sajjad Karim, Zeenat Mirza, Mohammad A. Kamal, Adel M. Abuzenadah, Esam I. Azhar, Mohammed H. Al-Qahtani and Sayed S. Sohrab


DOI: 10.2174/18715273113126660164






Alzheimer Disease and Type 2 Diabetes Mellitus: The Link to Tyrosine Hydroxylase and Probable Nutritional Strategies

, 13(3): 467 - 477

Gjumrakch Aliev, Khan Shahida, Siew Hua Gan, CK Firoz, Aziz Khan, Adel M. Abuzenadah, Warda Kamal, Mohammad A. Kamal, Yi Tan, Xianqin Qu and Marcella Reale


DOI: 10.2174/18715273113126660153


A Nanotechnological Approach to the Management of Alzheimer Disease and Type 2 Diabetes

, 13(3): 478 - 486

Qamre Alam, Mohammad ZubairAlam, Sajjad Karim, Siew H. Gan, Mohammad A. Kamal, Asif Jiman-Fatani, Ghazi A. Damanhouri, Adel M. Abuzenadah, Adeel G. Chaudhary and Absarul Haque


DOI: 10.2174/18715273113126660159


Molecular Interaction of Human Brain Acetylcholinesterase with a Natural Inhibitor Huperzine-B: An Enzoinformatics Approach

, 13(3): 487 - 490

Aftab Alam, Sibhghatulla Shaikh, Syed S. Ahmad, Mohammad A. Ansari, Shahnawaz Shakil, Syed M.D. Rizvi, Shazi Shakil, Mohammad Imran, Mohammad Haneef, Adel M. Abuzenadah and Mohammad A. Kamal


DOI: 10.2174/18715273113126660163




Structural and Functional Characterization of Pathogenic Non- Synonymous Genetic Mutations of Human Insulin-Degrading Enzyme by In Silico Methods

, 13(3): 517 - 532

Noor A. Shaik, Mohammed Kaleemuddin, Babajan Banaganapalli, Fazal Khan, Nazia S. Shaik, Ghada Ajabnoor, Sameer E. Al-Harthi, Nabeel Bondagji, Jumana Y. Al-Aama and Ramu Elango


DOI: 10.2174/18715273113126660161


Current View from Alzheimer Disease to Type 2 Diabetes Mellitus

, 13(3): 533 - 542

Mahmood Rasool, Arif Malik, Aamer M. Qazi, Ishfaq A. Sheikh, Abdul Manan, Sumaira Shaheen, Mahmood H. Qazi, Adeel G. Chaudhary, Adel M. Abuzenadah, Muhammad Asif, Mohammed H. Alqahtani, Zafar Iqbal, Munvar M. Shaik, Siew H. Gan and Mohammad A. Kamal


DOI: 10.2174/18715273113126660167





Editor-in-Chief

Cesar V. Borlongan
Department of Neurosurgery and Brain Repair
University of South Florida Morsani College of Medicine
Tampa, FL
USA

Biography View Full Editorial Board

Journal History

Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.
Track Your Manuscript:


Scopus CiteScore Metrics: 2.05

Related Journals

Related eBooks

eBooks Catalog